Report overview
This report contains market size and forecasts of Antidiabetic Drugs in global, including the following market information:
Global Antidiabetic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antidiabetic Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Antidiabetic Drugs companies in 2021 (%)
The global Antidiabetic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antidiabetic Drugs include Eli Lilly, Novartis, Boehringer Ingelheim, Merck, Novo Nordisk, Sanofi, AstraZeneca, Takeda and Bayer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antidiabetic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antidiabetic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Antidiabetic Drugs Market Segment Percentages, by Type, 2021 (%)
Oral Drugs
Injectable Drugs
Global Antidiabetic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Antidiabetic Drugs Market Segment Percentages, by Application, 2021 (%)
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus
Others
Global Antidiabetic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Antidiabetic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antidiabetic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antidiabetic Drugs revenues share in global market, 2021 (%)
Key companies Antidiabetic Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Antidiabetic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Novartis
Boehringer Ingelheim
Merck
Novo Nordisk
Sanofi
AstraZeneca
Takeda
Bayer
Pfizer
